5-hydroxymethylcytosine has been researched along with Heart Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfsnes, K; Aukrust, P; Bjørås, M; Brorson, SH; Christensen, G; Fiane, AE; Finsen, AV; Gullestad, L; Hildrestrand, GA; Iversen, PO; Johansen, J; Klungland, A; Kuśnierczyk, A; Louch, WE; Luna, L; Neurauter, CG; Ohm, IK; Olsen, MB; Palibrk, V; Scheffler, K; Sjaastad, I; Slupphaug, G; Sætrom, P; Vinge, LE; Wang, J; Yndestad, A; Zhang, L; Øgaard, JDS; Østlie, I | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Heart Failure
| Article | Year |
|---|---|
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture.
Topics: 5-Methylcytosine; Cell Proliferation; Collagen; Connective Tissue Diseases; DNA Damage; DNA Methylation; Endodeoxyribonucleases; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Heart-Assist Devices; Humans; Leukocytes; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myofibroblasts; N-Glycosyl Hydrolases; Oxidation-Reduction; Phenotype; Sequence Analysis, RNA; Survival Analysis; Time Factors | 2017 |